Page 1688 - Clinical Small Animal Internal Medicine

1626 Index

parasitic infections (cont’d) patterned alopecia 1436, 1436 intrapericardial cysts 275
VetBooks.ir otitis externa 1471, 1473–1474 pattern recognition receptors pericardiocentesis 280–284, 283
pattern recognition 731
pericardial effusion 277–284,
principles of therapy of dermatologic
282–283
(PRR) 422
diseases 1401–1402
rectoanal diseases 615 PCCL see percutaneous cystolithotomy peritoneopericardial diaphragmatic
parasitic skin diseases 1449–1460 PCD see plasma cell disorders hernia 275–277, 276
cheyletiellosis 1456–1457 PCNL see percutaneous pericardial effusion 277–284
demodicosis 1449–1454 nephrolithotomy cardiac neoplasia 1273
Dermanyssus gallinae 1458–1459 PCR see polymerase chain reaction cardiogenic shock 414, 416
Lynxacarus radovsky 1457–1458 PDA see patent ductus arteriosus diagnosis 278–280, 279–282
pediculosis 1459 PDH see pituitary‐dependent etiology/pathophysiology
scabies 1454–1456 hyperadrenocorticism 277–278
ticks 1460 PDK4 mutation 253, 259 history and clinical signs 278
trombiculosis 1459–1460 PE‐1 see pancreatic elastase signalment 278
parathyroid hormone (PTH) PE see pemphigus erythematosus treatment and prognosis
endocrinology 31–32 pediculosis 1459 280–284, 283
metabolic bone diseases PEEP see positive end‐expiratory pericardial tamponade 413, 416,
1521–1523 pressure 418–419
paraneoplastic syndromes 1217 PEG see percutaneous endoscopic pericardiocentesis 280–284, 283
phosphorus homeostasis and gastrostomy pericarditis 343
disorders 1079–1084 peliosis hepatis 673 perineal reflex 735
skeletal development and PEM see polioencephalomyelopathy perinuclear antineutrophilic
homeostasis 1515 pemphigus complex 1428–1430, 1429 cytoplasmic antibodies
parathyroid hormone‐related peptide pemphigus erythematosus (PE) 1430 (pANCA) 634
(PTH‐rp) 1217, 1522 pemphigus foliaceus (PF) periodontitis 533–536, 535
parenchymal disease 664–667, 1429–1430, 1429 period prevalence 18
665–666 pemphigus vegetans (PV) 1430 periosteal capillaries 1514
parenchymal structure 664 pemphigus vulgaris (PV) 542, 1430 periosteal trauma 1517
parenteral nutrition (PN) 453 penetrating trauma peripheral arterial pulsations
paresis/plegia epidemiology 447–449, 454 121–122
myelopathy 816–817, 821 oral cavity and salivary glands 542 peripheral nervous system (PNS)
neurologic assessment respiratory pattern‐based approach 789–792
731–734 to dyspnea 294 peritoneal dialysis 1175–1176
protozoal and protozoa‐like penicillins 1045 peritoneal‐pericardial diaphragmatic
infections 1006, 1006 penis 1313–1314 hernia 139
rabies 893 percutaneous cystolithotomy peritoneopericardial diaphragmatic
seizures and movement (PCCL) 1147–1149, 1148 hernia (PPDH) 275–277
disorders 770–771 percutaneous endoscopic gastrostomy diagnosis 275, 276
paroxysmal ventricular (PEG) tubes 527–529, 560 epidemiology 275
tachycardia 413–414 percutaneous nephrolithotomy etiology/pathophysiology 275
PARR see polymerase chain reaction for (PCNL) 1155 history and clinical signs 275
antigen receptor rearrangement percutaneous thrombogenic coil signalment 275
parvoviral enteritis 571 embolization (PTCE) 718, 720 treatment and prognosis
Pasteurella spp. 340 perforation 275–277
patella luxation (PL) 1546–1547 esophageal disorders 562 peritonitis 424–426
patent ductus arteriosus (PDA) large intestine 501 persistent atrial standstill 208–211
cardiovascular disease 123, 135, small intestine 494, 497 diagnosis 210, 210
149–151, 160 perfusion epidemiology/signalment 209
congenital heart disease 231, acute respiratory failure 384–385 etiology/pathophysiology
235–237, 241–244 cardiogenic shock 413 208–209
pulmonary hypertension 228 fluid therapy 360–361, 363–364 history and clinical signs 209
pathologic bone resorption shock 406 treatment and prognosis
1517–1518 perianal fistulae 613–614, 614, 615 210–211
patient preparation/positioning pericardial disease 275–285 persistent hyperinsulinemic
515, 517, 520, 522–525 congenital 275–277, 276 hypoglycemic syndrome
Patnaik grading system 1361 constrictive pericarditis 284–285 108–109